✦ LIBER ✦

A cost-effectiveness analysis of n-3 PUFA (Omacor®) treatment in post-MI patients

✍ Scribed by S. QUILICI; M. MARTIN; A. MCGUIRE; Y. ZOELLNER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS35 A Cost-Effectiveness Analysis of D

✍ K. Athanasakis; E. Karampli; M. Hollandezos; V. Papagiannopoulou; E. Badamgarav; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

A cost analysis of the treatment of pati

✍ Eduardo Ramacciotti; Marise Gomes; Eduardo Toledo de Aguiar; Jackson S. Caiafa; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Vaccination versus treatment of influenz

✍ Michael B. Rothberg; David N. Rose 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Cost-Effectiveness Analysis of Cysteamin

✍ Walczak, J.; Stelmachowski, J.; Obrzut, G.; Hubert, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Abatacept For The Treatment Of Patients

✍ Elgart, J.F.; Gonzalez, L.; Aiello, E.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

CV3 A COST-EFFECTIVENESS ANALYSIS OF CAN

✍ M Lamotte; L Annemans; B Schockaert 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB